404 Not Foundnginx/1.6.1 Financial Sector Fund August 30 News: Easy Standard & Poor's Healthcare A (RMB Share) Fund rose 0.23% on August 26, with a current price of 1.705 yuan and a transaction of 162,000 yuan. The current OTC net value of this fund is 1.6546 yuan, down 3.35% fro

404 Not Found

Financial Sector Fund August 30 News: Easy Standard & Poor's Healthcare A (RMB Share) Fund rose 0.23% on August 26, with a current price of 1.705 yuan and a transaction of 162,000 yuan. The current OTC net value of this fund is 1.6546 yuan, down 3.35% from the previous trading day, and the on-site price premium rate is 3.29%.

This fund is a listed tradable QDII fund , stock fund , and index fund . According to financial sector fund data, the net value of this fund fell by 1.59% in the past one month, and the net value of this fund fell by 1.71% in the past three months. , the net value of this fund fell by 2.31% in the past six months, and the net value of this fund fell by 8.07% in the past year. The cumulative net value of this fund since its establishment is 1.6546 yuan.

This fund has distributed 0 dividends since its establishment, with a cumulative dividend amount of 0 billion yuan. The fund is currently open for subscription. The fund manager of

is Song Zhaoxian. He has managed the fund since April 15, 2021, with a return of 5.05% during his tenure. The latest fund regular report of

shows that the fund holds a heavy position in Moderna Inc ( holding ratio of is 1.64%), Vertex Pharmaceuticals (position ratio is 1.62%), Eli Lilly (position ratio is 1.60%), Incyte Medical (position ratio is 1.57%), AbbVie (position ratio is 1.57%), Zoetis (position ratio 1.55%), UnitedHealth (position ratio 1.55%), Consego (position ratio 1.55%), Humana (position ratio 1.54%), Pfizer (position ratio 1.53% ).

Description and explanation of fund investment strategy and performance performance

The underlying index tracked by this fund is the S&P 500 Healthcare Equal Weight Index . The index component is the same as the global industry classification standard healthcare industry in the S&P 500 index component. During the reporting period, the Fund mainly adopts the complete replication method, that is, it constructs the fund's stock investment portfolio based entirely on the composition of the underlying index's constituent stocks and their weights, and makes corresponding adjustments based on changes in the underlying index's constituent stocks and their weights.

In the second quarter of 2022, the continuation of geopolitical risks has led to supply chain challenges for key commodities. Factors such as high oil prices, rising labor costs, and the imbalance between supply and demand caused by fiscal stimulus policies have rapidly pushed up U.S. inflation. Against this background the Federal Reserve accelerated the pace of monetary tightening, and announced in the June interest rate meeting statement that it would raise the federal funds rate by 75 basis points. Rising inflation and tightening financial conditions have impacted demand, and U.S. economic growth and corporate profit growth have gradually slowed down. The tightening pressure on the liquidity of the financial market has combined with investors' concerns about the risk of a U.S. economic recession, which has suppressed the market's risk appetite. US stocks have experienced an overall shock and decline, with volatility significantly amplified. The S&P 500 Healthcare Equal Weight Index oscillated downward during the reporting period, but overall continued to reflect the risk aversion attribute, and the decline was significantly smaller than the S&P 500 Index.

This reporting period is the normal operation period of the Fund. The Fund strictly abides by the fund contract during the investment operation process, adheres to the established index investment strategy, and applies index replication and quantitative techniques when adjusting index weights and changes in fund subscriptions and redemptions. Reduce impact costs and tracking errors, and strive to minimize tracking errors.